Previous Close | 0.4500 |
Open | 0.4500 |
Bid | 0.1600 |
Ask | 0.3500 |
Strike | 75.00 |
Expire Date | 2025-08-15 |
Day's Range | 0.4500 - 0.4500 |
Contract Range | N/A |
Volume | |
Open Interest | 756 |
PRINCETON, N.J., June 21, 2024--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with...
PRINCETON, N.J., June 21, 2024--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
PRINCETON, N.J., June 20, 2024--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024